These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38988467)

  • 1. Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models.
    Foldi CJ; Liknaitzky P; Williams M; Oldfield BJ
    Focus (Am Psychiatr Publ); 2024 Jul; 22(3):373-380. PubMed ID: 38988467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models.
    Foldi CJ; Liknaitzky P; Williams M; Oldfield BJ
    Front Neurosci; 2020; 14():43. PubMed ID: 32116500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms.
    Conn K; Milton LK; Huang K; Munguba H; Ruuska J; Lemus MB; Greaves E; Homman-Ludiye J; Oldfield BJ; Foldi CJ
    Mol Psychiatry; 2024 Oct; 29(10):3291-3304. PubMed ID: 38678087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms.
    Calder A; Mock S; Friedli N; Pasi P; Hasler G
    Eur Neuropsychopharmacol; 2023 Oct; 75():1-14. PubMed ID: 37352816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal Behavior in Psychedelic Research.
    Odland AU; Kristensen JL; Andreasen JT
    Pharmacol Rev; 2022 Oct; 74(4):1176-1205. PubMed ID: 36180111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology.
    Kelly DF; Heinzerling K; Sharma A; Gowrinathan S; Sergi K; Mallari RJ
    Neurosurgery; 2023 Apr; 92(4):680-694. PubMed ID: 36512813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond the numbers: reimagining healing with psychedelics for eating disorders.
    Lafrance A; Spriggs MJ; Gukasyan N; Peck SK
    J Eat Disord; 2024 Sep; 12(1):148. PubMed ID: 39350242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psilocybin-assisted psychotherapy as a potential treatment for eating disorders: a narrative review of preliminary evidence.
    Koning E; Brietzke E
    Trends Psychiatry Psychother; 2024; 46():e20220597. PubMed ID: 37126863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contribution of serotonin 5-HT
    Ibi D
    Nihon Yakurigaku Zasshi; 2023 May; 158(3):229-232. PubMed ID: 36990794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How Can Animal Models Inform the Understanding of Cognitive Inflexibility in Patients with Anorexia Nervosa?
    Huang K; Foldi CJ
    J Clin Med; 2022 May; 11(9):. PubMed ID: 35566718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid, automated, and experimenter-free touchscreen testing reveals reciprocal interactions between cognitive flexibility and activity-based anorexia in female rats.
    Huang K; Milton LK; Dempsey H; Power SJ; Conn KA; Andrews ZB; Foldi CJ
    Elife; 2023 Jun; 12():. PubMed ID: 37387293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders.
    Wulff AB; Nichols CD; Thompson SM
    Neuropharmacology; 2023 Jun; 231():109504. PubMed ID: 36921889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Brief Historical Overview of Psychedelic Research.
    Geyer MA
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2024 May; 9(5):464-471. PubMed ID: 38000715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice.
    Takaba R; Ibi D; Yoshida K; Hosomi E; Kawase R; Kitagawa H; Goto H; Achiwa M; Mizutani K; Maeda K; González-Maeso J; Kitagaki S; Hiramatsu M
    Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3019-3035. PubMed ID: 37874338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Differences in Psychedelic Actions Based on Biological Sex.
    Shadani S; Conn K; Andrews ZB; Foldi CJ
    Endocrinology; 2024 Jul; 165(8):. PubMed ID: 38980913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.
    Canal CE
    Handb Exp Pharmacol; 2018; 252():227-260. PubMed ID: 29532180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Psychedelics in Treatment-Resistant Depression.
    Kamal S; Jha MK; Radhakrishnan R
    Psychiatr Clin North Am; 2023 Jun; 46(2):291-305. PubMed ID: 37149346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.
    Ledwos N; Rosenblat JD; Blumberger DM; Castle DJ; McIntyre RS; Mulsant BH; Husain MI
    J Clin Psychopharmacol; 2022 Nov-Dec 01; 42(6):581-588. PubMed ID: 36193898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The psychedelic effects of cannabis: A review of the literature.
    Wolinsky D; Barrett FS; Vandrey R
    J Psychopharmacol; 2024 Jan; 38(1):49-55. PubMed ID: 37947321
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.